Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alok A Khorana

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Blood|July 25, 2015
The wacky hypercoagulable state of malignancyAlok A Khorana
Journal of the National Comprehensive Cancer Network : JNCCN|July 1, 2011
Risk assessment and prophylaxis for VTE in cancer patientsAlok A Khorana
Hematology. American Society of Hematology. Education Program|December 13, 2012
Cancer-associated thrombosis: updates and controversiesAlok A Khorana
Thrombosis Research|June 12, 2012
Risk assessment for cancer-associated thrombosis: what is the best approach?Alok A Khorana
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Venous thromboembolism prevention in cancer outpatientsAlok A Khorana
American Journal of Hematology|March 6, 2012
Cancer and coagulationAlok A Khorana
The Oncologist|December 7, 2007
The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patientsAlok A Khorana
Thrombosis Research|January 26, 2010
Venous thromboembolism and prognosis in cancerAlok A Khorana
Cancer Treatment and Research|July 19, 2019
Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary ProphylaxisJoanna Roopkumar, Alok A Khorana
Cancer Investigation|December 17, 2009
Cancer patients and awareness of venous thromboembolismTarek Sousou, Alok A Khorana
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Blood|July 25, 2015
The wacky hypercoagulable state of malignancyAlok A Khorana
Journal of the National Comprehensive Cancer Network : JNCCN|July 1, 2011
Risk assessment and prophylaxis for VTE in cancer patientsAlok A Khorana
Hematology. American Society of Hematology. Education Program|December 13, 2012
Cancer-associated thrombosis: updates and controversiesAlok A Khorana
Thrombosis Research|June 12, 2012
Risk assessment for cancer-associated thrombosis: what is the best approach?Alok A Khorana
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Venous thromboembolism prevention in cancer outpatientsAlok A Khorana
American Journal of Hematology|March 6, 2012
Cancer and coagulationAlok A Khorana
The Oncologist|December 7, 2007
The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patientsAlok A Khorana
Thrombosis Research|January 26, 2010
Venous thromboembolism and prognosis in cancerAlok A Khorana
Cancer Treatment and Research|July 19, 2019
Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary ProphylaxisJoanna Roopkumar, Alok A Khorana
Cancer Investigation|December 17, 2009
Cancer patients and awareness of venous thromboembolismTarek Sousou, Alok A Khorana
Pageof 21